Bioequivalence Study Between Two Oral Formulations of Famotidine Tablets Under Fasting Conditions

Randomized, 2-Way Crossover, Bioequivalence Study of Famotidine 40 mg Tablets Administered as 1 x 40 mg Tablet in Healthy Subjects Under Fasting Conditions

Compare the rate and extent of absorption of famotidine 40 mg tablets, administered as 1 x 40 mg tablet under fasting conditions.

Inclusion Criteria:

• healthy men or women 18 years of age or older
• body mass index below 30.0 kg/m2
• willing to participate and sin a copy of the informed consent form

Exclusion Criteria:

• recent history of drug or alcohol addiction or abuse
• pregnant or lactating women
• history of allergic response to heparin, famotidine, other H2-receptor antagonists, or other related drugs
• evidence of a clinically significant disorder or whose laboratory results were deemed to be clinically significant
• recipient of any drugs as part of a research study within 30 days prior to study dosing